Rise Advisors, LLC Exelixis, Inc. Transaction History
Rise Advisors, LLC
- $206 Million
- Q4 2024
A detailed history of Rise Advisors, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 1,189 shares of EXEL stock, worth $41,615. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,189
Previous 1,189
-0.0%
Holding current value
$41,615
Previous $30,000
30.0%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
569Shares Held
249MCall Options Held
1.72MPut Options Held
1.54M-
Black Rock Inc. New York, NY33.5MShares$1.17 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.03 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$820 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$535 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$399 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.3B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...